UCSF

ZINC00621893

Substance Information

In ZINC since Heavy atoms Benign functionality
July 25th, 2004 29 Yes

Other Names:

(+)-(2S,3S)-5-(2-(Dimethylamino)ethyl)-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate (ester),(S)-malate (1:1); 1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-(2-(di-methylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-(2S-cis

(+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester

(+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester; (2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate; (2S-cis)-3-(acetyl

(+)-cis-Diltiazem Hydrochloride

(+)-CIS-DILTIAZEM HYDROCHLORIDE; CPD000058375; Diltiazem hydrochloride; SAM002564204

(+)-CIS-DILTIAZEM HYDROCHLORIDE; CPD000058375; SAM002564204

(+)-cis-diltiazemhydrochloride

(2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate

(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate

(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate hydrochloride

(2S,3S)-5-[2-(dimethylamino)ethyl]-2-[4-(methyloxy)phenyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate

(2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one

tiazem

1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-cis)-

1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2S,3S)-

144604-00-2

144604-00-2; D03830; Diltiazem malate (USAN); Tiamate (TN)

183

33286-22-5

33286-22-5; Cardizem (TN); Cartia XT (TN); D00616; Dilacor XR (TN); Dilt-CD (TN); Diltiazem hydrochloride (JP16/USP)

33286-22-5; Diltiazem hydrochloride; Prestwick_176

42399-41-7

42399-41-7; C06958; Diltiazem

42399-41-7; D07845; Diltiazem (INN); Surazem (TN)

AC-936

AC1L2181

AC1Q6LHX

Acalix

Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester

Adizem

Aldizem

Altiazem

Anginyl

Angizem

Anoheal

Apo-Diltiaz

Bi-tildiem

BIDD:GT0548

Bio1_000371

Bio1_000860

Bio1_001349

BNP-32762

BPBio1_000230

BRD-A69636825-003-02-1

BRD-K24023109-001-02-5

BRD-K24023109-003-03-9

Britiazim

BRN 3573079

Bruzem

BSPBio_000208

BSPBio_001311

C06958

C22H26N2O4S

Calcicard

Cardil

Cardizem

Cardizem (Hydrochloride)

Cardizem CD

Cardizem LA

Cardizem SR

Cardizem XL

Cardizen LA

Cartia XT

Carzen

CHEBI:101278

CHEBI:4602

CHEMBL23

CID39186

Citizem

Cormax

CRD-401

d-cis-Diltiazem

D07845

DAP001262

DB00343

Deltazen

dil-

dil-; -tiazem

Dilacor

Dilacor-XR

Diladel

Dilcontin

Dilpral

Dilren

Dilrene

Dilt-cd

Dilta-Hexal

Diltia

Diltiazem (BAN

Diltiazem (hydrochloride)

Diltiazem (INN)

Diltiazem • HCl

Diltiazem HCl

Diltiazem HCl (Tiazac)

Diltiazem hydrochloride

Diltiazem Malate

Diltiazem Malate (FDA

DILTIAZEM MALATE; ENALAPRIL MALEATE; LS-187931; TECZEM

Diltiazem [INN:BAN]

Diltiazem.HCl

diltiazem; diltiazemum

Diltiazemum

Diltiazemum [INN-Latin]

Dilticard

Diltzac

Dilzem

Dilzen

Dilzene

DOV diltiazem

EINECS 255-796-4

Endrydil

FDA)

FT-0081415

Herbesser

HMS1791B13

HMS1989B13

HMS2089H09

HSDB 6528

Incoril AP

INN); Diltiazem Hydrochloride (FDA

INN); Diltiazem Malate (FDA

JAN

Lacerol

LS-40510

LS-40521

Masdil

MFCD00069252

MFCD00868239

Milptin

MK-793

MK-793 (Malate)

MK-793; RG-83606

MolPort-002-509-369

Mono-tildiem

N-DesmethylDiltiazemHydrochloride

NCGC00024309-02

NCGC00024309-04

NCGC00024309-05

NCGC00024309-06

NCGC00024309-07

NCGC00024309-08

NCGC00024309-09

NCGC00024309-10

nchembio.368-comp1

Novo-Diltazem

Nu-Diltiaz

Prestwick0_000134

Prestwick1_000134

Prestwick2_000134

Prestwick3_000134

RG 83606 (Hydrochloride)

RG 83606 HCl

RG-83606

Slozem

SLV-324

SPBio_002147

STOCK1N-03672

Surazem (TN)

Syn-Diltiazem

Tiamate

Tiazac

Tiazac Tildiem

Tiazac XC

Tildiem

Tocris-0685

Uni-Masdil

UNII-EE92BBP03H

USAN

USAN); Diltiazem (BAN

USAN); Diltiazem HCl (FDA

USAN); Diltiazem HCl (JAN

USP

USP)

VEN-307

Viazem

[(2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate

[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate hydrochloride

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.34 12.1 -42.54 1 6 1 60 415.535 7
Hi High (pH 8-9.5) 3.34 9.64 -12.57 0 6 0 59 414.527 7

Vendor Notes

Note Type Comments Provided By
Molecular_Solubility 4.353 Bitter DB
ALOGPS_SOLUBILITY 1.68e-02 g/l DrugBank-approved
MP 210 TCI
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Purity 99.5% Fluorochem
Purity >98% Fluorochem
Indications antihypertensive KeyOrganics Bioactives
Therapy Ca channel blocker, coronary vasodilator SMDC MicroSource
Therapy Ca2+ channel antagonist selective for slow, or L-type, channels; stimulates 1,4-dihydropyridine binding to Ca2+ channels SMDC Iconix
Target Calcium Channel Selleck Chemicals
UniProt Database Links CNGA3_BOVIN; CNGA3_HUMAN; CNGA3_MOUSE; CNGB3_CANFA; CNGB3_HUMAN; CNGB3_MOUSE; LAA1_YEAST ChEBI
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : D-4585; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER; 1 hydrogen chloride NIH Clinical Collection via PubChem
Target Others Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: D-4585; SALT: 1 hydrogen chloride; SUPPLIER_COMMENTS: WHITE POWDER NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
CAC1C-1-E Voltage-gated L-type Calcium Channel Alpha-1C Subunit (cluster #1 Of 1), Eukaryotic Eukaryotes 54 0.35 Binding ≤ 10μM
CAC1D-1-E Voltage-gated L-type Calcium Channel Alpha-1D Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 4700 0.26 Binding ≤ 10μM
CAC1E-1-E Voltage-gated R-type Calcium Channel Alpha-1E Subunit (cluster #1 Of 1), Eukaryotic Eukaryotes 4700 0.26 Binding ≤ 10μM
CAC1F-1-E Voltage-gated L-type Calcium Channel Alpha-1F Subunit (cluster #1 Of 1), Eukaryotic Eukaryotes 380 0.31 Binding ≤ 10μM
CAC1S-1-E Voltage-gated L-type Calcium Channel Alpha-1S Subunit (cluster #1 Of 1), Eukaryotic Eukaryotes 380 0.31 Binding ≤ 10μM
KCNH2-1-E HERG (cluster #1 Of 5), Eukaryotic Eukaryotes 4760 0.26 Binding ≤ 10μM
CAC1C-1-E Voltage-gated L-type Calcium Channel Alpha-1C Subunit (cluster #1 Of 1), Eukaryotic Eukaryotes 59 0.35 Functional ≤ 10μM
CAC1D-1-E Voltage-gated L-type Calcium Channel Alpha-1D Subunit (cluster #1 Of 1), Eukaryotic Eukaryotes 59 0.35 Functional ≤ 10μM
CP3A4-2-E Cytochrome P450 3A4 (cluster #2 Of 4), Eukaryotic Eukaryotes 500 0.30 ADME/T ≤ 10μM
Z50592-1-O Oryctolagus Cuniculus (cluster #1 Of 1), Other Other 1000 0.29 Binding ≤ 10μM
Z50512-1-O Cavia Porcellus (cluster #1 Of 7), Other Other 95 0.34 Functional ≤ 10μM
Z50592-3-O Oryctolagus Cuniculus (cluster #3 Of 8), Other Other 210 0.32 Functional ≤ 10μM
Z50597-1-O Rattus Norvegicus (cluster #1 Of 12), Other Other 790 0.29 Functional ≤ 10μM
Z50740-1-O Cricetinae Gen. Sp. (cluster #1 Of 2), Other Other 980 0.29 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
Z50592 Z50592 Oryctolagus Cuniculus 1000 0.29 Binding ≤ 1μM
CAC1C_RAT P22002 Voltage-gated L-type Calcium Channel Alpha-1C Subunit, Rat 16 0.38 Binding ≤ 1μM
CAC1D_RAT P27732 Voltage-gated L-type Calcium Channel Alpha-1D Subunit, Rat 16 0.38 Binding ≤ 1μM
CAC1F_HUMAN O60840 Voltage-gated L-type Calcium Channel Alpha-1F Subunit, Human 380 0.31 Binding ≤ 1μM
CAC1S_HUMAN Q13698 Voltage-gated L-type Calcium Channel Alpha-1S Subunit, Human 380 0.31 Binding ≤ 1μM
CAC1S_RAT Q02485 Voltage-gated L-type Calcium Channel Alpha-1S Subunit, Rat 16 0.38 Binding ≤ 1μM
CAC1E_RAT Q07652 Voltage-gated R-type Calcium Channel Alpha-1E Subunit, Rat 200 0.32 Binding ≤ 1μM
KCNH2_HUMAN Q12809 HERG, Human 4760 0.26 Binding ≤ 10μM
Z50592 Z50592 Oryctolagus Cuniculus 1000 0.29 Binding ≤ 10μM
CAC1C_RAT P22002 Voltage-gated L-type Calcium Channel Alpha-1C Subunit, Rat 16 0.38 Binding ≤ 10μM
CAC1D_RAT P27732 Voltage-gated L-type Calcium Channel Alpha-1D Subunit, Rat 16 0.38 Binding ≤ 10μM
CAC1F_HUMAN O60840 Voltage-gated L-type Calcium Channel Alpha-1F Subunit, Human 380 0.31 Binding ≤ 10μM
CAC1S_HUMAN Q13698 Voltage-gated L-type Calcium Channel Alpha-1S Subunit, Human 380 0.31 Binding ≤ 10μM
CAC1S_RAT Q02485 Voltage-gated L-type Calcium Channel Alpha-1S Subunit, Rat 16 0.38 Binding ≤ 10μM
CAC1E_RAT Q07652 Voltage-gated R-type Calcium Channel Alpha-1E Subunit, Rat 200 0.32 Binding ≤ 10μM
Z50512 Z50512 Cavia Porcellus 110 0.34 Functional ≤ 10μM
Z50740 Z50740 Cricetinae Gen. Sp. 980 0.29 Functional ≤ 10μM
Z50592 Z50592 Oryctolagus Cuniculus 1800 0.28 Functional ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 100 0.34 Functional ≤ 10μM
CAC1C_HUMAN Q13936 Voltage-gated L-type Calcium Channel Alpha-1C Subunit, Human 59 0.35 Functional ≤ 10μM
CAC1C_RAT P22002 Voltage-gated L-type Calcium Channel Alpha-1C Subunit, Rat 100 0.34 Functional ≤ 10μM
CAC1D_HUMAN Q01668 Voltage-gated L-type Calcium Channel Alpha-1D Subunit, Human 59 0.35 Functional ≤ 10μM
CAC1D_RAT P27732 Voltage-gated L-type Calcium Channel Alpha-1D Subunit, Rat 21 0.37 Functional ≤ 10μM
CP3A4_HUMAN P08684 Cytochrome P450 3A4, Human 2200 0.27 ADME/T ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Adrenaline,noradrenaline inhibits insulin secretion
Aflatoxin activation and detoxification
NCAM1 interactions
Regulation of insulin secretion
Voltage gated Potassium channels
Xenobiotics

Analogs ( Draw Identity 99% 90% 80% 70% )